VNO
60
10
WY
54
4
APD
59
2
CF
57
-2
HPQ
63
6
WAT
55
2
PLD
56
8
XRX
44
3
WEC
53
-2
GT
62
6
GPC
40
3
PFE
23
7
HCA
44
-2
ILMN
42
5
NVDA
56
-4
PYPL
54
2
LNC
39
3
NTAP
67
-3
EL
25
4
CA
38
6
VNO
60
10
WY
54
4
APD
59
2
CF
57
-2
HPQ
63
6
WAT
55
2
PLD
56
8
XRX
44
3
WEC
53
-2
GT
62
6
GPC
40
3
PFE
23
7
HCA
44
-2
ILMN
42
5
NVDA
56
-4
PYPL
54
2
LNC
39
3
NTAP
67
-3
EL
25
4
CA
38
6
Financhill
Back

Innate Pharma SA Vs. Cellectis SA Industry Stock Comparison

Sell
27

IPHA
Innate Pharma SA

Last Price:
1.58
Seasonality Move:
6.04%
Buy
57

CLLS
Cellectis SA

Last Price:
1.88
Seasonality Move:
2.08%
Sell
27
Innate Pharma SA (IPHA) is a Sell

Is Innate Pharma SA a Buy, Sell or Hold?

  • The current Innate Pharma SA [IPHA] share price is $1.63. The Score for IPHA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • IPHA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Cellectis SA (CLLS) is a Buy

Is Cellectis SA a Buy, Sell or Hold?

  • The current Cellectis SA [CLLS] share price is $1.87. The Score for CLLS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • CLLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IPHA Stock Price Chart

What is Innate Pharma SA's stock price today?

  • The Innate Pharma SA share price today is $1.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing slight buying pressure.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

  • The Cellectis SA share price today is $1.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing slight buying pressure.

IPHA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 42.81 Sell
Chaikin Money Flow: 999 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.64 - 1.92) Sell
Bollinger Bands (100): (1.88 - 2.3) Sell

CLLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 47.31 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.79 - 1.93) Buy
Bollinger Bands (100): (1.89 - 2.25) Sell

IPHA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.6 Buy
20-day SMA: 1.75 Sell
50-day SMA: 1.97 Sell
200-day SMA: 2.3 Sell
8-day EMA: 1.65 Sell
20-day EMA: 1.74 Sell
50-day EMA: 1.91 Sell
200-day EMA: 2.24 Sell

CLLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.91 Sell
20-day SMA: 1.86 Buy
50-day SMA: 1.98 Sell
200-day SMA: 2.35 Sell
8-day EMA: 1.89 Sell
20-day EMA: 1.89 Sell
50-day EMA: 1.96 Sell
200-day EMA: 2.23 Sell

Innate Pharma SA Earnings Growth & IPHA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.

Cellectis SA Earnings Growth & CLLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $0.06 per share.

Innate Pharma SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cellectis SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):